Portfolio manager comments — Q1 2025
Fund performance was negative in Q1 2025. During the period Germany and the EU launched major stimulus packages for investments in infrastructure and defense, while US equities posted a negative performance after a long period of excess returns against European equities. This resulted in passive inflows to Europe, primarily to larger companies and banks, which led to the weaker performance of small caps as a group relative to large caps. At the same time, the quarter was dominated by concerns about geopolitics and tariffs, which created volatility in the equity markets.
Fortnox, Uniphar, Embracer, CTP, Heijmans, Allegro and Biomerieux were the strongest positive contributors to fund returns. Companies such as Trainline, Embla Medical, Medcap, Applied Nutrition, and Do & Co continued to have a negative impact.
The fund invested in new holdings during the period which included Bank PKO, Barratt Redrow, Volution, Aalberts, HomeToGo and Ferrari Group. These purchases were financed through the sale of equities that included Munters, Indivior, Camurus, EDPR, Allfunds, Avanza, Publicis and Nexans.
So far this year we have seen a macro-driven market where investors are searching for exposure to Europe, which has led to significant passive inflows that have not yet reached the small caps. If this stabilizes, fund managers can move to small caps, which have had an unusually long period of underperformance relative to large caps. From a historical perspective, we believe that European small caps appear more attractive than large caps. We view the EU’s increased focus on reducing regulations and promoting growth and investments as positive for the region. The fund’s cautious view on the economy is supported by the thematic drivers among our holdings that help drive a probable earnings growth for the portfolio even if the economy remains weak.
The fund changed its portfolio manager to Gisela Gardelius on 1 March.